Yael Gruenbaum-Cohen is a General Partner at Entrée Bio (part of Entrée Capital), leveraging 15 years in healthcare to drive patient-centric HealthTech investments. With a Ph. D. in Molecular Genetics and a DMD from The Hebrew University, her career spans leadership roles at aMoon and Medison Ventures, focusing on advancing Israels HealthTech growth engine.
Passionate about elevating female leadership, Yael co-founded WE@HealthTech, a community that builds and supports female talent in the HealthTech industry. She is also highly involved in pro-bono medical-scientific support for the rare disease community, reflecting a deep commitment to translating science into patient impact.
She co-founded Andlit Therapeutics, a biotech company developing treatments for rare neurodevelopmental disorders.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.